Skip to main content

Amphetamine Psychosis—A Model for Paranoid Schizophrenia?

  • Chapter
Neuropharmacology and Behavior

Abstract

Amphetamine psychosis is at times strikingly similar to paranoid schizophrenia. How closely the exogenous model fits the endogenous psychosis is of vital interest. If such a model is valid, it would have great potential for explaining paranoid schizophrenia. This chapter presents a review of the strengths and weaknesses of amphetamine psychosis as a model for paranoid schizophrenia.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Anggard, E., Jonsson, L.-E., Hogmark, A.-L., and Grunne, L.-M., 1973, Amphetamine metabolism in amphetamine psychosis, Clin. Pharmacol. Ther. 14(5):870–880.

    PubMed  CAS  Google Scholar 

  • Angrist, B. M., Shopsin, B., and Gershon, S., 1971, Comparative psychotomimetic effects of stereoisomers of amphetamine, Nature, (London) 234:152–153.

    Article  CAS  Google Scholar 

  • Angrist, B., Shopsin, B., and Gershon, S., 1972, Metabolites of monamines in urine and cerebrospinal fluid, after large dose amphetamine administration, Psychopharmacologia (Berlin) 26:1–9.

    Article  CAS  Google Scholar 

  • Axelrod, J., 1972, Biogenic amines and their impact in psychiatry, Semin. Psychiatry 4(3): 199–210.

    PubMed  CAS  Google Scholar 

  • Bell, D. S., 1965, Comparison of amphetamine psychosis and schizophrenia, Br. J. of Psychiatry 111:701–707.

    Article  CAS  Google Scholar 

  • Bell, D. S., 1973, The experimental reproduction of amphetamine psychosis, Arch. Gen. Psychiatry 29:35–40.

    PubMed  CAS  Google Scholar 

  • Benakis, A., and Thomasset, M., 1970, Metabolism of amphetamines and their interaction with barbiturates and SKF-525A, in: Amphetamines and Related Compounds: Proceedings of the Mario Negri Institute for Pharmacologic Research, Milan, Italy (E. Costa and S. Garattini, eds.), pp. 153–164, Raven Press, New York.

    Google Scholar 

  • Bradley, C., 1937, The behavior of children receiving Benzedrine, Am. J. Psychiatry 94:577–585.

    Google Scholar 

  • Cameron, N., 1959, Paranoid conditions and paranoia, in: American Handbook of Psychiatry (S. Arieti, ed.), Vol. 1, p. 510, Basic Books, New York.

    Google Scholar 

  • Cameron, N., 1963, Personality Development and Psychopathology-A Dynamic Approach, p. 475, Houghton Mifflin Co., Boston.

    Google Scholar 

  • Cameron, N. A., 1967, Psychotic disorders. II. Paranoid reactions, in: Comprehensive Textbook of Psychiatry (Alfred M. Freedman and Harold I. Kaplan, eds.), p. 666, Williams & Wilkins Co., Baltimore.

    Google Scholar 

  • Chapman, A. H., 1954, Paranoid psychosis associated with amphetamine usage: A clinical note, Am. J. Psychiatry 111:43.

    PubMed  CAS  Google Scholar 

  • Connell, P. H., 1958, Amphetamine Psychosis, Chapman and Hall, London.

    Google Scholar 

  • Costall, B., Naylor, R. J., and Wright, T., 1972, The use of amphetamine-induced stereotyped behavior as a model for the experimental evaluation of antiparkinson agents, Arzneim.-Forsch. 22(7): 1178–1183.

    CAS  Google Scholar 

  • Coyle, J. T., and Snyder, S. H., 1969, Catecholamine uptake by synaptosomes in homogenates of rat brain: Stereospecificity in different areas, J. Pharmacol. Exp. Ther. 170:221–231.

    PubMed  CAS  Google Scholar 

  • Creese, I., and Iversen, S. D., 1975, The pharmacological and anatomical substrates of the amphetamine response in the rat, Brain Res. 83:419–436.

    Article  PubMed  CAS  Google Scholar 

  • Deffenu, G., Bartolini, A., and Pepeu, G., 1970, Effect of amphetamine on cholinergic systems of the cerebral cortex of the cat, in: Amphetamines and Related Compounds: Proceedings of the Mario Negri Institute for Pharmacologic Research, Milan, Italy (E. Costa and S. Garattini, eds.), pp. 357–368, Raven Press, New York.

    Google Scholar 

  • Delay, J., Pichot, P., Lemperiere, T., and Sadown, R., 1954, Ann. Med-Psychol. 112(2):51.

    CAS  Google Scholar 

  • DSM-II (Diagnostic and Statistical Manual of Mental Disorders), 1968, 2nd Ed., American Psychiatric Association, Washington, D.C.

    Google Scholar 

  • Ellinwood, E. H., Jr., 1967, Amphetamine psychosis. 1. Description of the individuals and process, J. Nerv. Ment. Dis. 144:273–283.

    Article  Google Scholar 

  • Ellinwood, E. H., Jr., 1972, Amphetamine psychosis: Individuals, settings, and sequences, in: Current Concepts on Amphetamine Abuse (E. H. Ellinwood and S. Cohen, eds.), p. 144, National Institute of Mental Health, Rockville, Maryland.

    Google Scholar 

  • Ellinwood, E. H., Jr., Sudilovsky, A., Nelson, L. M., 1973, Evolving behavior in the clinical and experimental amphetamine (model) psychosis, Am. J. Psychiatry 130(10): 1088–1093.

    PubMed  Google Scholar 

  • Ferris, R. M., Tang, F. L. M., Maxwell, R. A., 1972, A comparison of the capabilities of isomers of amphetamine, deoxypipradol and methylphenidate to inhibit the uptake of tritiated catecholamines into rat cerebral cortex slices, synaptosomal preparations of rat cerebral cortex, hypothalamus and striatum and into the adrenergic nerves of the rabbit aorta, J. Pharmacol. Exp. Ther. 181:407–416.

    PubMed  CAS  Google Scholar 

  • Fisher, E., Spatz, H., Saavedra, M., Reggiani, H., Miro, A. H., and Heller, B., 1972, Urinary elimation of phenylethylamine, Biol. Psychiatry 5(2): 139–147.

    Google Scholar 

  • Frey, H. H., 1970, p-Chloroamphetamine-similarities and dissimilarities to amphetamine, in: Amphetamines and Related Compounds: Proceedings of the Mario Negri Institute for Pharmacologic Research, Milan, Italy (E. Costa and S. Garattini, eds.), p. 343, Raven Press, New York.

    Google Scholar 

  • Fuxe, K., and Ungerstedt, U., 1968, Histochemical studies on the effect of (+)-amphetamine, drugs of the imipramine group and tryptamine on central catecholamine and 5-hydroxytryptamine neurons after intraventricular injection of catecholamines and 5-hydroxytryptamine, Eur. J. Pharmacol. 4:135–144.

    Article  PubMed  CAS  Google Scholar 

  • Gillin, J. C., Kaplan, J., Stillman, R. C., and Wyatt, R. J., 1976, The psychedelic model of schizophrenia: The case of N,N-dimethyl-tryptamine (DMT), Am. J. Psychiatry 133:203–208.

    PubMed  CAS  Google Scholar 

  • Goodwin, D. W., Alderson, P., and Rosenthal, R., 1971, Clinical significance of hallucinations in psychiatric disorders: A study of 116 hallucinatory patients, Arch. Gen. Psychiatry 24:76–80.

    PubMed  CAS  Google Scholar 

  • Griffith, J. D., Cavanaugh, J., Held, J., and Oates, J. A., 1970, Experimental psychosis induced by the administration of d-amphetamine, in: Amphetamines and Related Compounds: Proceedings of the Mario Negri Institute for Pharmacologic Research, Milan, Italy (E. Costa and S. Garattini, eds.), pp. 897–904, Raven Press, New York.

    Google Scholar 

  • Griffith, J. D., Cavanaugh, J., Held, J., and Oates, J. A., 1972, Dextroamphetamine: Evaluation of psychotomimetic properties in man. Arch. Gen. Psychiatry 26:97–100.

    PubMed  CAS  Google Scholar 

  • Grunne, E., and Lewander, T., 1967, Long-term effects of some dependence-producing drugs on the brain monamines, in: Molecular Basis of Some Aspects of Mental Activity (O. Wahaas, ed.), Vol. 2, pp. 75–81, New York.

    Google Scholar 

  • Harris, J. E., and Baldessarini, R. J., 1973, Uptake of [3H]catecholamines by homogenates of rat corpus striatum and cerebral cortex: Effects of amphetamine analogues, Neuropharmacology 12:669–679.

    Article  PubMed  CAS  Google Scholar 

  • Heikkila, R. E., Orlansky, H., Mytilineou, C., and Cohen, G., 1975, Amphetamine: Evaluation of d-and l-isomers as releasing agents and uptake inhibitors for 3H-dopamine and 3H-norepinephrine in slices of rat neostriatum and cerebral cortex, J. Pharmacol. Exp. Ther. 194:47–56.

    PubMed  CAS  Google Scholar 

  • Himmelhoch, J. M., Detre, T., Kupfer, D. J., and Byck, R., 1972, Treatment of previously intractable depressions with tranylcypromine and lithium, J. Nerv. Ment. Dis. 155:216–220.

    Article  PubMed  CAS  Google Scholar 

  • Hollister, L. E., 1968a, Human pharmacology of lysergic acid diethylamide (LSD), in: Psychopharmacology: A Review of Progress 1957–1967 (D. H. Efron, ed.), Public Health Service Publication 1836, pp. 1253–1261, U.S. Government Printing Office, Washington, D.C.

    Google Scholar 

  • Hollister, L. E., 1968b, Chemical Psychoses, pp. 117–126, Charles C. Thomas, Springfield, Illinois.

    Google Scholar 

  • Hornykiewicz, O., 1966, Dopamine 3-hydroxytryptamines and brain function, Pharmacol. Rev. 18(2):925–964.

    PubMed  CAS  Google Scholar 

  • Innes, I. R., and Nickerson, M., 1970, Amphetamine, in: The Pharmacological Basis of Therapeutics (Louis S. Goodman and Alfred Gilman, eds.), 3rd Ed., p. 501, Macmillan Co., New York.

    Google Scholar 

  • Janowski, D. S., El-Yousef, K., Davis, J. M., Sekerke, H. J., 1973, Antagonist effects of physostigmine and methylphenidate in man, Am. J. Psychiatry 130(12): 1370–1376.

    Google Scholar 

  • Kalant, O. J., 1966, The Amphetamines-Toxicity and Addiction, p. 53, Charles C. Thomas, Springfield, Illinois.

    Google Scholar 

  • Kety, S. S., 1959, Biochemical theories of schizophrenia, Science 129:1–12.

    Google Scholar 

  • Knoll, J., 1973, Modulation of learning and retention by amphatamines, in: Pharmacology and the Future of Man: Proceedings of the Fifth International Congress on Pharmacology, San Francisco 1972, Vol. 4, pp. 55–68, S. Karger, Basel.

    Google Scholar 

  • Kramer, J. C., 1969, Introduction to amphetamine abuse, J. Psychedelic Drugs 11(2):1–16.

    Google Scholar 

  • Layne, O. L., Jr., and Yudofsky, S. C., 1971, Postoperative psychosis in cardiotomy patients: Role of organic and psychiatric factors, N. Engl. J. Med. 284:518–520.

    Article  PubMed  Google Scholar 

  • Lehmann, H. E., 1967, Schizophrenia: Clinical features, in: Comprehensive Textbook of Psychiatry (Alfred M. Freedman and Harold I. Kaplan, eds.), p. 629, Williams & Wilkins Co., Baltimore. Licit and Illicit Drugs, 1972 (Edward M. Brecher & the Editors of Consumers Reports eds.), Consumers Union, Mt. Vernon, New York.

    Google Scholar 

  • Munkvad, I., Pakkenberg, H., and Randrup, A., 1968, Aminergic systems in basal ganglia associated with stereotyped behavior and catelepsy, Brain Behav. Evol. 1:89–100.

    Article  Google Scholar 

  • Nathanson, M. H., 1939, The central action of beta-amino-aminopropyl benzene (Benzedrine): Clinical observations, J. Am. Med. Assoc. 108:528–531.

    Google Scholar 

  • Penn, H., Racy, J., Lapham, L., Mandel, M., and Sandt, J., 1972, Catatonic behavior, viral encephalopathy, and death, Arch. Gen. Psychiatry 27:758–761.

    PubMed  CAS  Google Scholar 

  • Post, R. M., 1973, Simulated behaviour states: An approach to specificity in psychobiological research, Biol. Psychiatry 7:237–254.

    PubMed  CAS  Google Scholar 

  • Prange, A. J., Wilson, I. C., Lynn, C. W., Allsop, L. B., and Stikeleather, R. A., 1974, l-Tryptophan in mania: Contribution to a permissive hypothesis of affective disorders, Arch. Gen. Psychiatry 30:56–62.

    PubMed  Google Scholar 

  • Prinzmetal, M., and Bloomberg, W., 1935, The use of Benzedrine for the treatment of narcolepsy, J. Am. Med. Assoc. 105:2051–2054.

    CAS  Google Scholar 

  • Randrup, A., and Munkvad, I., 1967, Stereotyped activities produced by amphetamine in several animal species and man, Psychopharmacologia (Berlin) 11:300–310.

    Article  CAS  Google Scholar 

  • Randrup, A. and Munkvad, I., 1970, Biochemical, anatomical, and psychological investigations of stereotyped behavior induced by amphetamines, in: Amphetamines and Related Compounds: Proceedings of the Mario Negri Institute for Pharmacologic Research, Milan, Italy (E. Costa and S. Garattini, eds.), pp. 695–713, Raven Press, New York.

    Google Scholar 

  • Rosenthal, D., 1970, Genetic Theory and Abnormal Behavior, McGraw-Hill, New York.

    Google Scholar 

  • Ross, S. B., and Renyi, A.-L., 1975, Inhibition of uptake of 3H-dopamine and 14C-5-hydroxytryptamine in mouse striatum slices, Acta Pharmacol. Toxicol. 36:56–66.

    Article  CAS  Google Scholar 

  • Saavedra, J. M., 1974, Enzymatic isotopic assay for and presence of β-phenylethylamine in brain, J. of Neurochem. 22:211.

    Article  CAS  Google Scholar 

  • Schildkraut, J. J., 1969, Neuropsychopharmacology and the affective disorders, N. Engl. J. Med. 281:302–306.

    Article  PubMed  CAS  Google Scholar 

  • Schildkraut, J. J., 1972, Neuropharmacologically generated models of the affective disorders: Biochemical versus behavioral models, Psychopharmacol. Bull. 8(3):61–62.

    Google Scholar 

  • Schildkraut, J. J., and Kety, S. S., 1967, Biogenic amines and emotion, Science 156(3771):21–30.

    Article  PubMed  CAS  Google Scholar 

  • Simpson, S. I., 1975, Blood pressure and heart rate responses evoked by d- and l-amphetamine in the pithed rat preparation, J. Pharmacol. Exp. Ther. 193:149–159.

    PubMed  CAS  Google Scholar 

  • Slater, E., 1959, Amphetamine psychosis, Br. Med. J. 1:488.

    Article  Google Scholar 

  • Snyder, S. H., 1972, Catecholamines in the brain as mediators of amphetamine psychosis, Arch. Gen. Psychiatry 27:169–179.

    PubMed  CAS  Google Scholar 

  • Stevens, J. R., 1973, An anatomy of schizophrenia?, Arch. Gen. Psychiatry 29:177–189.

    PubMed  CAS  Google Scholar 

  • Taylor, K. M., and Snyder, S. H., 1970, Amphetamine: Differentiation by d and l isomers of behavior involving brain norepinephrine or dopamine, Science 168:1487–1489.

    Article  PubMed  CAS  Google Scholar 

  • Thornburg, J. E., and Moore, K. E., 1973, Dopamine and norepinephrine uptake by rat brain synaptosomes: Relative inhibitory potencies of l-and d-amphetamine and amantadine, Res. Commun. Chem. Pathol. Pharmacol. 5:81–89.

    PubMed  CAS  Google Scholar 

  • Tsuang, M. T., and Winokur, G., 1974, Criteria for sub-typing schizophrenia: Clinical differentiation of hebephrenia and paranoid schizophrenia, Arch. Gen. Psychiatry 31:43–47.

    PubMed  CAS  Google Scholar 

  • Ungerstedt, U., 1971, Stereotaxic mapping of the monamine pathways in the rat brain, Acta Physiol. Scand. 367(Suppl.): 1–48.

    CAS  Google Scholar 

  • Van Rossum, J. M., 1970, Mode of action of psychomotor stimulant drugs, Int. Rev. Neurobiol. 12:307–383.

    Article  PubMed  Google Scholar 

  • Wallis, G. G., McHarg, J. F., and Scott, O. C. A., 1949, Acute psychosis caused by dextroamphetamine, Br. Med. J., 2:1394.

    Article  PubMed  CAS  Google Scholar 

  • Waud, S. P., 1938, The effects of toxic doses of benzyl methyl carbinamine (Benzedrine) in man, J. Am. Med. Assoc. 110:206.

    CAS  Google Scholar 

  • Welch, B. L., and Welch, A. S., 1970, Control of brain catecholamines and serotonin during acute stress and after d-amphetamine by natural inhibition of monamine-oxidase: An hypothesis, in: Amphetamines and Related Compounds: Proceedings of the Mario Negri Institute for Pharmacologic Research, Milan, Italy (E. Costa and S. Garattini, eds.), pp. 415–445, Raven Press, New York.

    Google Scholar 

  • Wilson, I. C., Prange, A. J., Jr., and Laura, P. P., Methyltestosterone with imipramine in men: Conversion of depression to paranoid reaction, Am. J. Psychiatry 131(1): 21–24.

    Google Scholar 

  • Wyatt, R. J., Murphy, D. L., Belmaker, R., Cohen, S., Donnelly, C. H., and Pollin, W., 1973, Reduced monamine oxidase activity in platelets: A possible genetic marker for vulnerability to schizophrenia, Science 179:916–918.

    Article  PubMed  CAS  Google Scholar 

  • Wyatt, R. J., Potkin, S. G., Gillin, J. C., and Murphy, D. L., 1977a, Enzymes involved in phenylethyalmine and catecholamine metabolism in schizophrenics and controls in: Psychopharmacology: A Review of Progress 1967–1976 (M. Lipton and A. DiMascio, eds.), Raven Press, New York (in press).

    Google Scholar 

  • Wyatt, R. J., Gillin, J. C., Stoff, D. M., Moja, E. A., and Tinklenberg, J. R. 1977b, β- Phenylethylamine (PEA) and the neuropsychiatric disturbances, in: Neuroregulators and Psychiatric Disorders (E. Usdin, J. Barchas, and D. Hamburg, eds.), pp. 31–45, Oxford University Press. New York.

    Google Scholar 

  • Young, D., and Scoville, W. B., 1938, Paranoid psychosis in narcolepsy and the possible danger of Benzedrine treatment, Med. Clin. North Am. 22:637–646.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1978 Plenum Press, New York

About this chapter

Cite this chapter

Woodrow, K.M., Reifman, A., Wyatt, R.J. (1978). Amphetamine Psychosis—A Model for Paranoid Schizophrenia?. In: Haber, B., Aprison, M.H. (eds) Neuropharmacology and Behavior. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-3961-8_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-3961-8_1

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-3963-2

  • Online ISBN: 978-1-4613-3961-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics